IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Memorial Sloan Kettering Cancer Center
Institut Bergonié
Beth Israel Deaconess Medical Center
Institut Bergonié
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
Wake Forest University Health Sciences
Seoul National University Hospital
Washington University School of Medicine
University of Michigan Rogel Cancer Center
Mie University